Tech Company Financing Transactions

Seventh Sense Biosystems Funding Round

Seventh Sense Biosystems secured a $10 million Series C funding round on 11/17/2016. Investors included Flagship Pioneering, Laboratory Corporation of America and Novartis Venture Fund.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Medical Devices & Instruments

Mailing Address

200 Boston Ave. 3700
Medford, MA 02155
USA

Phone

(617) 547-7246

Website

www.7sbio.com

Email Address

[email protected]

Overview

The company's proprietary TAP Touch Activated Phlebotomy technology enables painless, convenient and safe blood collection and is the foundation for a rich pipeline of products from painless, one-step sampling to integrated collection and analysis for a total decentralized testing solution

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Harry Wilcox

        

Chief Operating Officer

Timothy Richards

        

Chief Scientific Officer

Howard Bernstein

        

VP - Bus. Development

Stuart Blitz

        

VP - Engineering

Jerry Brightbill

        

Browse more venture capital transactions:

Prev: 11/17/2016: Firefly Learning venture capital transaction
Next: 11/17/2016: Atomicorp venture capital transaction

Share this article

About Our VC Transactions Data

Our team works diligently to report on tech company VC transactions. VC investment data records on this site are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary